Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

510

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

December 31, 2008

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Iodofiltic acid I 123

Trial Locations (38)

13210

Syracuse

40207

Louisville

48085

Troy

64111

Kansas City

95661

Roseville

Unknown

Birmingham

Huntsville

Mesa

Los Angeles

Mission Viejo

Newport Beach

Hartford

New Haven

Newark

Jacksonville

Aurora

Maywood

Auburn

Bethesda

Detroit

Royal Oak

Minneapolis

Lebanon

Manchester

Albany

Brooklyn

Kingston

New York

Rochester

Cincinnati

Cleveland

Columbus

Providence

Houston

Richmond

Madison

North Vancouver

Scarborough Village

All Listed Sponsors
lead

Molecular Insight Pharmaceuticals, Inc.

INDUSTRY